Safety of intra-arterial chemotherapy with or without osmotic blood–brain barrier disruption for the treatment of patients with brain tumors
Kutluay Uluç(Oregon Health & Science University), Edward A. Neuwelt(Oregon Health & Science University), Prakash Ambady(Legacy Health), Seymur Gahramanov, Ryan Priest(Oregon Health & Science University), Caleb Nerison(Western University of Health Sciences), Amy Huddleston(Oregon Health & Science University), John Philip Tabb(Oregon Health & Science University), João Prola Netto, Leslie L. Muldoon(Oregon Health & Science University), Aclan Dog⫧an(Oregon Health & Science University), Jesse Liu(Oregon Health & Science University), Dominic A. Siler(University of Wisconsin–Madison), Cymon Kersch(Oregon Health & Science University), Matthew K. McIntyre(Oregon Health & Science University), Rongwei Fu(Oregon Health & Science University)
Cited by 24
Related Papers
Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits
|Proceedings of the National Academy of Sciences|2007|784
Engaging neuroscience to advance translational research in brain barrier biology
|Nature reviews. Neuroscience|2011|586
Potassium Modulates Electrolyte Balance and Blood Pressure through Effects on Distal Cell Voltage and Chloride
|Cell Metabolism|2015|455
Chemotherapy Delivery Issues in Central Nervous System Malignancy: A Reality Check
|Journal of Clinical Oncology|2007|414